Lupus (SLE) trials in France

In France 51 Also abroad 354

51 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Enrolling by invitation
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Where
Saint-Denis
Age
18 years to 75 years
People
680 worldwide
Run by
Viatris Innovation GmbH
See details and how to joinNCT06475742 · EU 2024-514354-67-00
Phase 1Not yet taking people in France
Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
Where
Villejuif
Age
18 years to 75 years
People
6
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07544225
No phaseTaking people
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
Where
Strasbourg
Age
18 years to 70 years
People
200
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07251179
Phase 1Taking people
A Phase 1 Study of the Safety and Preliminary Efficacy of CTX112 in Adult Subjects With Refractory Autoimmune Disease.
Where
Clermont-Ferrand, Créteil, Grenoble Cedex 9, Toulouse Cedex 9
Age
18 years and over
People
51 worldwide
Run by
CRISPR Therapeutics AG
See details and how to join2024-518528-54-00 · EU 2024-518528-54-00
Phase 1Taking people
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
Where
Montpellier, Strasbourg Cedex 2
Age
18 years to 75 years
People
36 worldwide
Run by
AbbVie
See details and how to joinNCT06977724 · EU 2024-519157-10-00
Phase 2Not yet taking people in France
Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial
Where
Amiens Cedex 1, Angers, Bordeaux, Boulogne-Billancourt, Caen, Corbeil-Essonnes, Creteil, Dijon, Fort De France Cedex, Grenoble Cedex 9, Le Kremlin-Bicetre, Lille Cedex, Marseille, Montpellier Cedex 5, Montreuil, Nantes, Nice, Nimes Cedex 9, Paris, Paris Cedex 18, Paris Cedex 20, Pierre-Bénite, Rouen, Saint-Pierre, St Denis, Strasbourg, Suresnes, Toulouse Cedex 9, Tours, Valenciennes
Age
18 years to 75 years
People
65
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07721363 · EU 2024-519985-35-00
No phaseNot yet taking people in France
Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus
Where
Bordeaux, Toulouse
Age
1 year to 18 years
People
105
Run by
University Hospital, Bordeaux
See details and how to joinNCT07680010
Phase 1Taking people
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Where
Lille Cedex, Strasbourg Cedex 2
Age
18 years and over
People
125 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00
No phaseTaking people
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
Where
Marseille
Age
18 years and over
People
300 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06527872
No phaseTaking people
Immun4Cure Cohort of Autoimmune Diseases
Where
Montpellier
Age
18 years and over
People
500
Run by
University Hospital, Montpellier
See details and how to joinNCT07515638
No phaseTaking people
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU
Where
Brest
Age
18 years and over
People
300
Run by
University Hospital, Brest
See details and how to joinNCT06551389
Phase 1Taking people
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Where
Bordeaux, Toulouse Cedex 9
Age
18 years to 70 years
People
44 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00
No phaseTaking people
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Where
Paris
Age
18 years and over
People
5,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07077304
Phase 1Taking people
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Where
Paris
Age
12 years to 70 years
People
244 worldwide
Run by
Fate Therapeutics
See details and how to joinNCT06308978
No phaseTaking people
Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus
Where
Bordeaux
Age
18 years and over
People
120
Run by
University Hospital, Bordeaux
See details and how to joinNCT07260942
No phaseTaking people
Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus
Where
Tours
Age
18 years and over
People
50
Run by
University Hospital, Tours
See details and how to joinNCT05859191
No phaseTaking people
HLA Antibodies in Systemic Lupus Erythematosus
Where
Amiens
Age
18 years and over
People
30
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT06921239
Phase 3Taking people
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
Where
Amiens, Amiens Cedex 1, Angers, Avignon Cedex 9, Bordeaux, Boulogne-Billancourt, Brest, Caen, Clermont-Ferrand, Clermont Ferrand Cedex 1, Corbeil Essonnes Cedex, Creteil, Creteil Cedex, Dijon, Fort De France Cedex, Le Kremlin-Bicetre, Le Mans Cedex 9, Lille Cedex, Limoges Cedex 1, Lyon Cedex 02, Lyon Cedex 07, Marseille, Metz, Nantes, Nice, Nîmes, Paris, Paris Cedex 13, Paris Cedex 18, Pessac, Pierre-Bénite, Pringy Cedex, Rouen, Strasbourg, Suresnes, Toulouse, Toulouse Cedex 9, Tours Cedex 9, Valenciennes
Age
14 years and over
People
196
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04702256 · EU 2024-516242-19-00
No phaseTaking people
Systemic Lupus Erythematosus and Accelerated Aging
Where
Bordeaux
Age
18 years to 60 years
People
75
Run by
University Hospital, Bordeaux
See details and how to joinNCT05698173
No phaseTaking people
Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique
Where
Fort-de-France
Age
18 years and over
People
200
Run by
University Hospital Center of Martinique
See details and how to joinNCT06365359
No phaseTaking people
Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
Where
Strasbourg
Age
18 years and over
People
352
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT05927688
No phaseTaking people
Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation
Where
Brest
Age
18 years to 80 years
People
150
Run by
University Hospital, Brest
See details and how to joinNCT04320680
No phaseTaking people
ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
Where
Strasbourg
Age
18 years to 70 years
People
450
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT06593041
No phaseTaking people
Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
Where
Reims
Age
18 years and over
People
260
Run by
CHU de Reims
See details and how to joinNCT06462768
Phase 2Not yet taking people in France
Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus
Where
Bordeaux, Bron, Clermont-Ferrand, Grenoble, Lille, Lyon, Paris, Pierre-Bénite, Saint-Priest-en-Jarez
Age
12 years to 65 years
People
70
Run by
Hospices Civils de Lyon
See details and how to joinNCT06356740 · EU 2023-508611-22-00